Breed predispositions, clinical findings, and prognostic factors for death in dogs with nonregenerative immune‐mediated anemia
Autor: | Vanessa L. Woolhead, James W. Swann, Antonia Chan, Balazs Szladovits, Barbara Glanemann |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
bone marrow 040301 veterinary sciences Anemia Standard Article 030204 cardiovascular system & hematology Logistic regression rubriphagocytosis Cohort Studies 0403 veterinary science 03 medical and health sciences IMHA Dogs 0302 clinical medicine Interquartile range Internal medicine medicine Animals Dog Diseases Reticulocytopenia Retrospective Studies PIMA General Veterinary business.industry Case-control study Hematology 04 agricultural and veterinary sciences Odds ratio Prognosis medicine.disease Standard Articles Breed Case-Control Studies CHAOS SMALL ANIMAL Anemia Hemolytic Autoimmune business Cohort study |
Zdroj: | Journal of Veterinary Internal Medicine |
ISSN: | 1939-1676 0891-6640 |
DOI: | 10.1111/jvim.15986 |
Popis: | Background Breed predispositions, survival, and prognostic factors have not been evaluated in dogs with nonregenerative immune-mediated anemia (nrIMA). Hypothesis/objectives To describe clinicopathologic variables, evaluate their associations with survival, and determine breed predispositions for dogs with nrIMA. Animals Fifty-nine client-owned dogs with nrIMA. Methods Referral hospital records were reviewed retrospectively for dogs with primary nrIMA (PCV ≤30%, corrected reticulocyte percentage (CR%) ≤1.0, bone marrow sampling with evidence of immune-mediated destruction, and underlying causes excluded). Breed predispositions were evaluated by calculation of odds ratios in a case control study; prognostic factors by logistic regression in a cohort study. Results Fifty-nine dogs with nrIMA had a median PCV of 12% (interquartile range [IQR]: 10%-17%) and CR% 0.1 (0%-0.2%). At least ≥1 ACVIM IMHA diagnostic criteria were met by 35 dogs (59%). Whippets, Lurchers, and miniature Dachshunds were predisposed to nrIMA. Median survival time was 277 days (IQR: 37-1925), with 3- and 12-month survival rates 61% and 43%, respectively. Erythroid regeneration and remission were achieved by 88% and 62% of dogs, respectively. Corrected reticulocyte percentage >0.2 was associated with improved survival. Conclusion and clinical importance Although there is overlap of clinical features between dogs with IMHA and nrIMA, the prognosis for those with nrIMA depends predominantly on the severity of reticulocytopenia. |
Databáze: | OpenAIRE |
Externí odkaz: |